Evaluation of Intralymphatic Immunotherapy in Allergic Rhinitis Patients: A Systematic Review and Meta-analysis

Figure 7

Adverse events after injection. (a) Local urticarial reaction, (b) local swelling or erythema, (c) abdominal pain or nausea, (d) fatigue, (e) eye or nasal symptoms, (f) headache, and (g) pulmonary symptoms. ILIT: intralymphatic immunotherapy; CI: confidence interval; df: degrees of freedom.

(a)

(b)

(c)

(d)

(e)

(f)

(g)